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Abstract
Functional dyspepsia and lactose intolerance (adult-type hypolactasia, ATH) are common conditions that may coex-
ist or even be confounded. Their clinical presentation can be similar, however, lactose intolerance does not form part
of the diagnostic investigation of functional dyspepsia. Studies on the association between functional dyspepsia and
ATH are scarce. This study aimed to evaluate whether ATH is associated with symptoms of functional dyspepsia.
Patients fulfilling the Rome III diagnostic criteria for functional dyspepsia underwent genetic testing for ATH. Dyspep-
tic symptoms were evaluated and scored according to a validated questionnaire. The diagnostic criteria for ATH was
a CC genotype for the -13910C/T polymorphism, located upstream of the lactase gene. The mean scores for dyspep-
tic symptoms were compared between patients with ATH and those with lactase persistence. A total of 197 functional
dyspeptic patients were included in the study. Mean age was 47.7 years and 82.7% patients were women.
Eighty-eight patients (44.7%) had a diagnosis of ATH. Abdominal bloating scores were higher in ATH patients com-
pared to the lactase persistent patients (P=0.014). The remaining dyspeptic symptom scores were not significantly
different between the two groups. The study results demonstrate an association between ATH and bloating in pa-
tients with functional dyspepsia.
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Dyspepsia affects more than 20% of the world popu-
lation (Ford et al., 2015). It corresponds to a group of diges-
tive symptoms with heterogeneous pathophysiology. Most
patients with dyspeptic symptoms have functional dyspep-
sia (FD), which means no underlying cause was identified
during diagnostic evaluation (Talley and Ford, 2015). Ac-
cording to the Rome IV criteria, FD is characterized by one
or more of the following: postprandial fullness, early satia-
tion, epigastric pain and epigastric burning, which are un-
explained after routine clinical evaluation. FD includes two
subcategories: postprandial distress syndrome (PDS) that is
characterized by meal-induced dyspeptic symptoms, and
epigastric pain syndrome (EPS) that does not occur exclu-
sively postprandially; the two subgroups can overlap (Stan-
ghellini et al., 2016). The current definition, specifically for
FD, represents a slight modification from the previous
Rome III criteria, with the purpose of improving the speci-
ficity of definitions of syndrome’s symptoms. Rome IV
emphasizes PDS and EPS subtypes rather than focusing on
the syndrome as a whole (Talley et al., 2016).
The majority of the world’s population has deficiency
of lactase activity in adulthood (Mattar et al., 2012). Lac-
tase non-persistence after infancy results from a genetically
determined condition known as adult-type hypolactasia
(ATH), which is the main cause of lactose intolerance
(Misselwitz et al., 2013). Single nucleotide polymorphisms
(SNPs) located upstream of the lactase gene are associated
with ATH (Enattah et al., 2002). The most important SNPs
are known as -13910C/T and -22018G/A, and genetic test-
ing is currently available as a non-invasive method to diag-
nose this condition (Rasinperä et al., 2004; Högenauer et
al., 2005; Krawczyk et al., 2008; Pohl et al., 2010; Missel-
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witz et al., 2013). The most common symptoms of lactose
intolerance are abdominal bloating, diarrhea, flatulence,
nausea and vomiting (Levitt et al., 2013). However, these
symptoms are not specific and may be caused by other con-
ditions, such as functional gastrointestinal disorders
(FGIDs) (Drossman, 2006; Jellema et al., 2010).
Lactose intolerance and FGIDs are common condi-
tions that may coexist or even be confounded. There may be
some overlap between the symptoms of lactose intolerance
and functional dyspepsia. A few particular symptoms, such
as abdominal bloating, nausea and vomiting, may be attrib-
uted to both conditions (Drossman, 2006; Jellema et al.,
2010; Levitt et al., 2013). Indeed, the pathophysiology of
FD is complex, heterogeneous and not yet completely un-
derstood (Vanheel and Farré, 2013). More recently, the role
of dietary factors in FD has been increasingly recognized
(Feinle-Bisset et al., 2004, Feinle-Bisset and Azpiroz,
2013; Shepherd et al., 2013).
Conceptually, the diagnosis of functional dyspepsia
implies a lack of evidence of any organic, systemic or meta-
bolic disease that is likely to explain the symptoms (Stan-
ghellini et al., 2016). However, investigation of lactose
intolerance (which is caused by adult-type hypolactasia)
does not currently form a part of the diagnostic testing for
dyspepsia. In a recent review of the role of diet in FD,
Feinle-Bisset and Azpiroz (2013) stated the importance of
recognizing potential organic causes for symptom induc-
tion, including gluten and lactose intolerance and food al-
lergies. Data on the association between lactose intolerance
and functional dyspepsia are scarce (Mishkin et al., 1997;
Wilder-Smith et al., 2013). Therefore, this potential associ-
ation needs additional investigation.
The aim of the present study was to evaluate whether
adult-type hypolactasia is associated with symptoms of
functional dyspepsia.
This study was nested in the HEROES trial (Helico-
bacter Eradication Relief of Dyspeptic Symptoms trial;
ClinicalTrials.gov No. NCT00404534) (Mazzoleni et al.,
2011). This was a randomized, double-blind, placebo-con-
trolled, clinical trial carried out in a single academic hospi-
tal (Hospital de Clínicas de Porto Alegre). In summary,
patients with dyspeptic symptoms were recruited from re-
ferrals, from primary care settings, and through advertising
media. Patients of either sex aged 18 years or more were in-
cluded if they had a diagnosis of functional dyspepsia ac-
cording to the Rome III criteria. Symptoms must have been
present for more than six months, with at least one episode
per week of epigastric pain, burning, discomfort, postpran-
dial fullness, or early satiety, during the previous three
months. All patients underwent an esophagogastroduo-
denoscopy with gastric and duodenal biopsies, and only
those who tested positive for Helicobacter pylori (from
both histopathological examination and urease test) were
included in the trial. Patients with findings suggestive of or-
ganic diseases, such as cancer of the upper gastrointestinal
tract, erosive esophagitis, peptic ulcer disease and/or celiac
disease were excluded. Patients with irritable bowel syn-
drome (IBS) were also excluded. Other exclusion criteria
have been previously detailed (Mazzoleni et al., 2011).
Dyspeptic symptoms were evaluated through a previ-
ously structured and validated questionnaire (Porto Alegre
Dyspeptic Symptoms Questionnaire - PADYQ) (Sander et
al., 2004). This 11-item instrument assesses the three most
important symptoms of FD (upper abdominal pain, abdom-
inal bloating and early satiety) and also nausea and vomit-
ing, during the preceding 30 days. The total score ranges
from 0 (absence of symptoms) to 44 (severe symptoms).
This procedure enables evaluation of the severity of each
symptom through its frequency, intensity and duration. Ac-
cording to the predominant symptoms, patients were either
considered to have PDS (bothersome postprandial fullness
and/or early satiation, and possibly upper abdominal bloat-
ing or postprandial nausea or excessive belching) or EPS
(epigastric pain or burning, and supporting criteria, as
stated previously). In the present study, we considered ex-
clusively the clinical evaluation of symptoms of FD per-
formed at baseline in the HEROES trail.
All patients had blood samples stored, which were
used for DNA extraction and subsequent analysis of ATH-
associated polymorphisms. The local Institutional Review
Board approved the study protocol, and informed consent
was obtained from all patients (including permission for
genetic testing) (protocol number GPPG-HCPA 100473).
DNA extraction from the blood samples was fol-
lowed by polymerase chain reaction (PCR) amplification.
Genotyping of the -13910C/T SNP (rs4988235) was per-
formed by DNA sequencing, as described by Ingram et al.
(2007). The diagnostic criterion for ATH was a CC geno-
type at SNP -13910C/T. A CT or TT genotype indicated the
absence of ATH, which corresponds to lactase persistence.
This choice is justified as this SNP has a 100% penetrance
and is considered the most important ATH-associated SNP
(Enattah et al., 2002; Misselwitz et al., 2013).
Quantitative data were described as means and stan-
dard deviations, and qualitative data as frequencies and per-
centages. The allele frequencies were determined by direct
counting of the alleles, and deviations from the Hardy-
Weinberg equilibrium were evaluated by a chi-square test.
Mean age was compared between groups by Student’s
t-test. The mean PADYQ scores for upper abdominal pain,
abdominal bloating, early satiety, nausea and vomiting
were compared between patients classified as having ATH
and those having lactase persistence by the Mann-Whitney
U test. Categorical variables were compared using the chi-
square or Fisher’s exact tests, as appropriate. A p value of <
0.05 was considered significant. Statistical analyses were
performed using PASW 18.0 (SPSS Inc., Chicago, USA).
Of 404 patients with functional dyspepsia and posi-
tive for H. pylori who were included in the HEROES Trial
(Mazzoleni et al., 2011), 197 consented to participate in
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this nested study aiming the analysis of the lactase gene
polymorphism. Table 1 shows the demographic and clini-
cal characteristics of the 197 patients with functional dys-
pepsia enrolled in the present study. The mean age was 47.7
 11.9 years and 163 (82.7%) were female. The mean
PADYQ total score was 19.9  7.1. A total of 104 (52.8%)
patients had predominant symptoms categorized as PDS
and 93 (47.2%) as EPS.
According to the -13910C/T genotyping, 88/197 pa-
tients (44.7%) had ATH. The genotype frequencies of the
-13910C/T polymorphism were as follows: CC, 88/197
(44.7%); CT, 89/197 (45.2%); and TT, 20/197 (10.1%).
The frequency of the T allele was 32.7%. No deviation
from the Hardy-Weinberg equilibrium was observed
(p=0.718). Seventy-one (80.7%) patients with ATH were
white, compared to 96 (88.1%) of the lactase persistent pa-
tients (p=0.15). Similarly, there were no significant differ-
ences in other demographic and clinical characteristics
between the two groups (Table 1).
The results of the comparison between the scores for
dyspeptic symptoms and lactase activity status are shown
in Table 2. The total score for dyspeptic symptoms
(PADYQ total score) was similar between patients with
ATH (19.94  6.32) and lactase persistence (18.31  7.67)
(p=0.134). However, comparison of the mean score for
each symptom between the two groups showed bloating to
be significantly higher in the ATH group (9.06  2.55),
compared to the lactase persistent group (8.32  2.71)
(p=0.014). In addition, although no statistically significant
difference was seen, there was a tendency for more symp-
toms of nausea in the ATH group (p=0.063). Symptoms of
epigastric pain, early satiety and vomiting had similar mean
scores between the two groups. Similarly, there were no
statistically significant differences in the frequency of ATH
between FD subtypes (Table 1).
The present study evaluated whether adult-type hypo-
lactasia is associated with symptoms of functional dyspep-
sia. Almost half the patients with FD in the sample were
lactase deficient (diagnosed as ATH according to genetic
testing). The frequency of ATH in our study is in accor-
dance with the prevalence rates previously described in
Brazilian populations (Bernardes-Silva et al., 2007; Mattar
et al., 2009; Friedrich et al., 2012). Our results showed that
functional dyspepsia patients with ATH had higher bloat-
ing scores in comparison to those with lactase persistence.
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Table 1 - Demographic and clinical characteristics of 197 patients with functional dyspepsia according to lactase activity status (ATH versus lactase per-
sistent).
Variable Total (n=197) ATH* (n=88) Lactase persistent (n=109) p
Age, mean  SD (years) 47.7  11.9 47.4  11.1 48.0  12.6 0.700
Female, n (%) 163 (82.7) 74 (84.1) 89 (81.7) 0.652
Race (white), n (%) 167 (84.8) 71 (80.7) 96 (88.1) 0.151
Coffee drinker, n (%) 131 (66.5) 62 (70.5) 69 (63.3) 0.290
Smoking status, n (%) 0.183
Never 113 (57.4) 56 (63.6) 57 (52.3)
Current/Former 84 (42.6) 32 (36.4) 52 (47.7)
Alcohol intake, n (%) 0.428
Never 170 (86.3) 73 (83.0) 97 (89.0)
Current/Former 27 (13.7) 15 (17.0) 12 (11.0)
Duration of dyspepsia > 5 years, n (%) 94 (47.7) 44 (50.0) 50 (45.9) 0.286
Functional dyspepsia categories, n (%) 0.876
Postprandial distress syndrome 104 (52.8) 47 (53.4) 57 (52.3)
Epigastric pain syndrome 93 (47.2) 41 (46.6) 52 (47.7)
*ATH: Adult-type hypolactasia
Table 2 - Total and individual symptom scores (PADYQ) according to
lactase activity status (-13910C/T SNP genotypes).
PADYQ* score ATH** Lactase persistent p
-13910 CC
(n=88)
-13910 CT + TT
(n=109)
Upper abdominal pain 7.17  3.31 7.06  3.59 0.867
Nausea 4.85  3.94 3.73  4.06 0.063
Vomiting 0.37  0.73 0.41  0.97 0.458
Abdominal bloating 9.06  2.55 8.32  2.71 0.014
Early satiety 2.06  1.55 1.96  1.50 0.634
Total score 19.94  6.32 18.31  7.67 0.134
Data are presented as the mean  standard deviation or number (percent-
age).
*PADYQ: Porto Alegre Dyspeptic Symptoms Questionnaire (Sander et
al., 2004)
**ATH: Adult-type hypolactasia
The remaining dyspeptic symptom scores did not differ sig-
nificantly between these two groups.
A homogeneous sample of patients with FD was ana-
lyzed. All patients underwent a thorough evaluation in or-
der to establish a diagnosis of FD. The rigorous diagnostic
evaluation performed, including an upper gastrointestinal
endoscopy with gastric and duodenal biopsies, aimed at ex-
cluding from the sample any patients with other overlap-
ping or confounding conditions. Clinical evaluation was
performed using a structured, validated questionnaire, giv-
ing an effective and reproducible assessment of FD symp-
toms (Sander et al., 2004). This instrument allowed a
thorough evaluation of the symptoms (intensity, frequency
and duration), both individually and as a whole. Lactase ac-
tivity status was assessed through molecular analysis and
patients were classified either as ATH or lactase persistent
(non-ATH), according to the genetic test result. ATH is ul-
timately the major cause of lactose intolerance and an ex-
cellent genotype-phenotype correlation has been reported
for the -13910C/T SNP (Rasinperä et al., 2004; Högenauer
et al., 2005; Ridefelt and Håkansson, 2005; Anthoni et al.,
2007; Bulhões et al., 2007; Usai Satta et al., 2008; Pohl et
al., 2010). Thus, this non-invasive diagnostic approach was
performed in order to investigate the association between
adult-type hypolactasia and symptoms of functional dys-
pepsia.
Food ingestion is associated with symptom onset or
exacerbation in a significant proportion of patients with
FGIDs (Feinle-Bisset and Azpiroz, 2013). The role of food
has been more extensively studied in IBS. A consistent
body of evidence has linked FODMAPs (fermentable,
oligo-, di-, monosaccharides, and polyols) and IBS, as re-
viewed by Shepherd et al. (2013). In particular, the poten-
tial relevance of lactase deficiency in IBS symptoms has
been a matter of debate for decades, yielding mixed results
(Brandt et al., 2009). Dietary factors also seem to be impor-
tant in FD (Carvalho et al., 2010; Feinle-Bisset and Azpi-
roz, 2013; Shepherd et al., 2013; Goktas et al., 2016).
However, the role of the ingestion of milk and dairy prod-
ucts in symptoms of patients with FD is still unclear. Some
authors have evaluated the frequency of lactose intolerance
or malabsorption and ATH in patients with dyspeptic com-
plaints (Mishkin et al., 1997; Di Stefano et al., 2009; Mattar
et al., 2009; Wilder-Smith et al., 2013). Three of these stud-
ies have either heterogeneous samples (also including pa-
tients with FGIDs other than FD) or poorly characterized
dyspeptic patients (Mishkin et al., 1997; Di Stefano et al.,
2009; Mattar et al., 2009). An observational study with a
large sample conducted by Wilder-Smith et al. (2013) eval-
uated lactose intolerance and malabsorption in 606 func-
tional dyspeptic patients. In total, 49.7% of these patients
were classified as lactose intolerant. However, symptoms
were not evaluated according to status of lactase activity.
Additionally, none of these studies were specifically de-
signed to evaluate FD symptoms in relation to ATH or
lactose intolerance.
The similarity of some clinical aspects of FD and lac-
tose intolerance provides a rational basis for the present
investigation. In particular, bloating is a common and both-
ersome symptom that may form part of the clinical presen-
tation of FGIDs, such as IBS and FD (Knill-Jones, 1985;
Talley et al., 1989; Lembo et al., 1999; Longstreth et al.,
2006). Indeed, bloating is also considered one of the typical
symptoms in the definition of lactose intolerance (Mis-
selwitz et al., 2013). Since genetic testing for ATH corre-
lates well with lactase activity (Rasinperä et al., 2004;
Högenauer et al., 2005; Pohl et al., 2010; Bulhões et al.,
2007; Usai Satta et al., 2008; Anthoni et al., 2007; Ridefelt
and Håkansson, 2005), it seems reasonable to consider the
possibility of such an underlying pathophysiological mech-
anism to explain the finding of higher bloating scores
among patients with lactase deficiency (ATH). In our un-
derstanding, the same may also explain a tendency of
higher nausea scores in this group of patients. Besides, it
would be unreasonable to find a pathophysiologic basis to
explain symptoms like early satiety, epigastric and vomit-
ing in the context of ATH. Thus, our observation that there
is no association of ATH and total score for dyspeptic
symptoms, and also early satiety, epigastric pain and vom-
iting individually, highlights the association of ATH and
bloating observed in our patients with FD. Moreover, a pos-
sible bias due to the overlap between FD and IBS is un-
likely, since patients with IBS were not included in our
sample because of a rigorous initial diagnostic evaluation.
Thus, the findings of the present study indicate the possible
presence of a subgroup of so-called “functional dyspeptic”
patients who have one identifiable organic mechanism,
which relates to lactase deficiency, or ultimately, lactose
intolerance.
Some limitations in this study must be considered.
First, we acknowledge there may be some influence of H.
pylori gastritis itself in the pathophysiological basis of
bloating in the patients studied. Currently, Rome IV criteria
define H. pylori-associated dyspepsia in those patients with
long term sustained remission of symptoms after bacterial
successful eradication. Since all recruited patients had H.
pylori infection at inclusion in the HEROES trial, the symp-
toms of the patients studied could be, at least in part, related
to H. pylori gastritis itself. Unfortunately, study design is
limited to elucidate the complex interaction between these
factors. Additionally, another limitation of the present
study is the lack of dietary information regarding milk and
derivatives ingestion. This is due to the fact that the present
study was conceived after the HEROES study.
In conclusion, the findings of the present study dem-
onstrate an association between adult-type hypolactasia
and bloating in patients with functional dyspepsia. It is sug-
gested that patients with functional dyspepsia who present
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with bloating should be evaluated for adult-type hypo-
lactasia.
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